Get the Weekly Intelligence Brief — top committee picks every Sunday.
SYK · NASDAQ · STOCK

Stryker Corporation

Healthcare Updated August 08, 2026
$338.92
52W $281.00 – $396.86
53/100
$129.97B
34.8
0.78
AI Committee Verdict
Watch
53/100
Conviction: Contested · 33% agreement · 6 analysts
+10.3%
-2.6%
4.01:1
Contested

Is SYK Bullish or Bearish?

Mixed. Innellis AI committee rates Stryker Corporation (SYK) Watch with a composite score of 53/100 , based on 6 analysts with 33% agreement. Last updated August 08, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +7.09 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -12.91 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — market regime is bullish (bull market -- normal position sizing). Risk Analyst remains cautious — bollinger bandwidth of 15.4% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 15.1% shows genuine earnings power backing the valuation — Value
  • MACD histogram positive -- bullish momentum — Technical
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • News sentiment is positive (+0.33 across 46 articles, 14d) — News
Bear Case
  • P/E of 39.0 is moderate-to-rich — Value
  • Price-to-book of 6.0x prices in significant intangible value — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • Bollinger bandwidth of 15.4% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 08, 2026
Overall Committee Score
53/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 90%
of 95 Healthcare peers
Value Analyst neutral
48 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 15.1% shows genuine earnings power backing the valuation
− P/E of 39.0 is moderate-to-rich
Growth Analyst bearish
38 / 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 15.4% signals elevated volatility
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
68 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.33 across 46 articles, 14d)
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 4 existing position pair(s) are highly correlated already
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 52.9 to 52.9.

Analyst-level changes:
  • News Analyst: +1 bullish signal(s).
  • Risk Analyst: +1 bearish signal(s).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-08-07 to 2026-08-08 (1 day apart).

Technical Analysis

RSI (14)
55.1
Neutral
MACD Histogram
0.149
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$330.18
Resistance
$373.99
Bollinger %B
0.67
Inside Bands
Price vs Moving Averages
EMA 9
$336.69 Above
EMA 21
$331.76 Above
EMA 50
$325.49 Above
EMA 200
$338.45 Above

Fundamental Analysis

Valuation
49
Growth
24
Profitability
78
Financial Health
97
Cash Flow
70
Valuation
P/E Ratio 34.8×
P/B Ratio 5.42×
PEG Ratio 1.28
Dividend Yield 1.03%
52W High $396.86
52W Low $281.00
Quality & Growth
ROE 1447.8%
ROA 678.5%
Gross Margin 6516.6%
Operating Margin 2202.7%
Revenue Growth YoY
Debt / Equity 0.62
AI Fundamental Assessment
P/E ratio of 34.8 (rich relative to a 15-40x range); Price-to-book of 5.4x; PEG ratio of 1.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 14.5%; Return on assets of 6.8%; Net margin of 14.4%; Gross margin of 65.2%; Current ratio of 2.16 (healthy short-term liquidity); Debt-to-equity of 0.62; Free cash flow per share is positive (12.26); Most recent quarter missed estimates by 13.7%; EPS growth decelerating (+0.0% -> -41.8% QoQ); Analyst estimates falling over recent quarters
Get the Full SYK Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore SYK Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime